Search This Blog

Wednesday, April 28, 2021

Teva misses on revenue, reaffirms guidance in Q1

 

  • Revenues of $4.0 billion

  • GAAP diluted EPS of $0.07

  • Non-GAAP diluted EPS of $0.63

  • Cash flow used in operating activities of $405 million

  • Free cash flow of $59 million

  • Full year 2021 business outlook reaffirmed:

    • Net revenues of $16.4-16.8 billion

    • EBITDA of $4.8 - $5.1 billion

    • EPS of $2.50 - $2.70

    • Free cash flow of $2.0 - $2.3 billion

  • https://finance.yahoo.com/news/teva-reports-first-quarter-2021-110000380.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.